Literature DB >> 30528803

Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti-programmed death 1 antibody.

T Shirai1, Y Kiniwa2, R Sato1, T Sano1, K Nakamura1, Y Mikoshiba1, N Ohashi3, Y Sekijima3, R Okuyama1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30528803     DOI： 10.1016/j.ejca.2018.10.025

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.

Authors:  Ranjan Pathak; Anjan Katel; Erminia Massarelli; Victoria M Villaflor; Virginia Sun; Ravi Salgia
Journal:  Oncologist       Date:  2021-08-25

2.  Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature.

Authors:  Yuki Nakagomi; Kazuko Tajiri; Saori Shimada; Siqi Li; Keiko Inoue; Yoshiko Murakata; Momoko Murata; Shunsuke Sakai; Kimi Sato; Masaki Ieda
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

3.  Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma.

Authors:  Naoya Okubo; Toshiki Kijima; Akinori Nukui; Takao Kamai
Journal:  BMJ Case Rep       Date:  2020-09-09

4.  Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.

Authors:  Naoki Hamada; Ayaka Maeda; Kaoru Takase-Minegishi; Yohei Kirino; Yumiko Sugiyama; Ho Namkoong; Nobuyuki Horita; Ryusuke Yoshimi; Hideaki Nakajima
Journal:  Front Immunol       Date:  2021-12-06       Impact factor: 7.561

5.  Association Between Clinical Factors and Result of Immune Checkpoint Inhibitor Related Myasthenia Gravis: A Single Center Experience and Systematic Review.

Authors:  Jiayu Shi; Ying Tan; Yangyu Huang; Ke Li; Jingwen Yan; Yuzhou Guan; Li Zhang
Journal:  Front Neurol       Date:  2022-04-07       Impact factor: 4.003

Review 6.  Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors.

Authors:  Omoruyi Credit Irabor; Nicolas Nelson; Yash Shah; Muneeb Khan Niazi; Spencer Poiset; Eugene Storozynsky; Dinender K Singla; Douglas Craig Hooper; Bo Lu
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.